7 results
10-K
2021 FY
ACXP
Acurx Pharmaceuticals, Inc.
16 Mar 22
Annual report
4:05pm
QIDP and Fast Track Designations
The GAIN Act, which was enacted as part of the Food and Drug Administration Safety and Innovation Act (“FDASIA
424B4
ACXP
Acurx Pharmaceuticals, Inc.
28 Jun 21
Prospectus supplement with pricing info
6:02am
(GAIN) Act, which was enacted as part of the Food and Drug Administration Safety and Innovation Act (“FDASIA”) in 2012, created incentives … Product) listed in GAIN Act legislation of 2012 enacted as part of the Food and Drug Administration Safety and Innovation Act (FDASIA). A QIDP is defined
S-1/A
ACXP
Acurx Pharmaceuticals, Inc.
11 Jun 21
IPO registration (amended)
6:02am
and Innovation Act (“FDASIA”) in 2012, created incentives for the development of novel antibiotic and antifungal products intended to treat serious and life … Administration Safety and Innovation Act (FDASIA). A QIDP is defined as “an antibacterial or antifungal drug for human use intended to treat serious or life
S-1
ACXP
Acurx Pharmaceuticals, Inc.
27 May 21
IPO registration
12:00am
Designations
The Generating Antibiotic Incentives Now (GAIN) Act, which was enacted as part of the Food and Drug Administration Safety and Innovation Act … Safety and Innovation Act (FDASIA). A QIDP is defined as “an antibacterial or antifungal drug for human use intended to treat serious or life-threatening
DRS/A
gmoagdb
10 May 21
Draft registration statement (amended)
12:00am
DRS
484m9k9 tde9bh
5 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next